US Procedure Numbers for Interventional Cardiology Devices 2015- MedPro

US Procedure Numbers for Interventional Cardiology Devices 2015- MedPro

0

  • Year: 2015
  • Scope: 2011-2021
  • Region: United States
  • Published Date: 12/01/2015
  • Pages: 50
  • Type: MedPro

Interventional cardiology is a minimally-invasive technique that uses catheters to treat coronary arterial disease, which is one of the leading causes of death in the United States. The most common interventional cardiology procedure is percutaneous transluminal coronary angioplasty (PTCA), which is performed for the management of coronary atherosclerosis.
There are many different types of complementary devices used during interventional cardiology procedures. These devices include coronary stents, PTCA and cutting balloon catheters, balloon-inflation devices, interventional coronary catheters and guidewires, coronary embolic protection devices, coronary atherectomy devices, coronary thrombectomy devices, coronary chronic total occlusion devices, coronary introducer sheaths, coronary vascular closure devices, diagnostic coronary catheters and guidewires, fractional flow reserve (FFR) guidewires, intravascular ultrasound (IVUS) catheters and optical coherence tomography (OCT) catheters.

Segments Covered in this Interventional Cardiology Procedure Volume Research

This market study focuses specifically on the volume of procedures in the interventional cardiology market. It includes analysis of procedures in the following segments:

  • Angiography Procedures
  • Angioplasty/PCI Procedures
  • Catheterization Procedures

This data is then displayed over the forecast period, 2011-2021, outlining the exact growth rates for procedures in these segments. If you’re interested in seeing the trends in procedures to formulate your market sizing and forecasts this is the most accurate and most affordable way to do it.

About Procedure Volume Research (MedPro)

Our analysts meticulously research for 3 to 4 months to put together a suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedPro is one portion of that analysis that outlines only the procedure volumes and forecasts for each market in that suite of reports.

This procedural analysis is incorporated in our market size analysis and forecasting which are available when purchasing a MedSuite, MedView or MedCore. For a deeper description on these product types click here or contact us to have a product consultant help you find the data you need.

Where Do We Get Interventional Cardiology Procedure Data?

Our team of analysts has proprietary data that we’ve been collecting for over a decade as well as government and private databases like that from CMS and hospital records. By looking at multiple sources we are able to triangulate on interventional cardiology procedure volumes that influence and coincide with our overall market sizing.

Trends Affecting the Interventional Cardiology Market

Over the forecast period, the U.S. market for interventional cardiology is expected to decrease at a CAGR of -0.4%, largely due to the decreases in stenting implantation. Since the bare-metal and drug-eluting stent market is significantly large, the growth trends experienced by this market will play a large role in the future growth of the overall interventional cardiology market. Overall angioplasty and angiography procedures have been declining over the last few years, resulting in the majority of the included segments experiencing notable decreases.

Questions This Report will Help You Answer

  • What is affecting the volume of procedures in U.S.?
  • How many procedures were done in 2014?
  • How many procedures were done historically?
  • How many procedures can we expect in 2021 and what is the growth trend?


The "European Markets for Interventional Cardiology Devices 2015 - MedSuite" includes analysis on the following companies currently active in this market:
Boston Scientific
Abbott Laboratories
Medtronic
Biotronik
St. Jude Medical
Cordis
Terumo
Volcano Therapeutics
B. Braun
Hexacath
Biosensors
Others include: Blue Medical, Bolton Medical, Cardiovascular Systems Inc, C.R. Bard, Elixir Medical Corp, Invatec

*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Thank you!

CLOSE
Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.

CLOSE

Login

Sign Up

Already have an account? Sign in

×